Investigational Site Number 076001

Porto Alegre 90620-001

0 studies enrolling now · 10 studies all time

What they study most

Acute Coronary Syndrome, Asthma, Atherosclerotic Cardiovascular Disease, Fabry Disease, Prostate Cancer, Small Cell Lung Cancer, Sphingomyelin Lipidosis

Studies at this site

• A Long-Term Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency — Completed
• Evaluation of Dupilumab in Children With Uncontrolled Asthma — Completed
• Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) — Completed
• Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency — Completed
• A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease — Stopped early
• Cabazitaxel Versus Docetaxel Both With Prednisone in Patients With Metastatic Castration Resistant Prostate Cancer — Completed
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab — Completed
• Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) — Completed
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy — Completed
• Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer — Completed